Associations between abcc2 polymorphisms and cisplatin disposition and efficacy
Clinical Pharmacology & Therapeutics, 05/14/2012Sprowl JA et al.
These SNPs were also not correlated with ABCC2 expression in the NCI60 panel (P > 0.26) or with cisplatin–induced cytotoxicity (P = 0.21). These findings highlight the importance of verifying drug–transporter interactions with in vitro tests in humans.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.